Login / Signup
In silico drug repositioning of FDA-approved drugs to predict new inhibitors for alpha-synuclein aggregation.
Sedighe Sadat Jafaripour
Sajjad Gharaghani
Elmira Nazarshodeh
Shozeb Haider
Ali Akbar Saboury
Published in:
Comput. Biol. Chem. (2020)
Keyphrases
</>
drug resistance
human immunodeficiency virus
drug design
drug discovery
pharmaceutical industry
data aggregation
virtual screening
temporal sequences
data sets
neural network
machine learning
computer vision
image sequences
computer simulation
biological data
protein protein interactions